Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Murrell

Showing results (391-400 of 491) with videos related to

Pageof 50
Sort By:
International Journal of Women'S Dermatology|May 12, 2017
The reliability and validity of outcome measures for atopic dermatitis in patients with pigmented skin: A grey areaC Y Zhao, A Wijayanti, M C Doria, et al.
Clinical and Experimental Dermatology|March 17, 2023
Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the Phase IIb CONTROL studyChristopher G Bunick, Joyce M C Teng, Scott Guenthner, et al.
The British Journal of Dermatology|May 14, 2013
A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopyP L Tong, J Qin, C L Cooper, et al.
Clinical and Experimental Dermatology|August 21, 2008
Clinical heterogeneity in recessive epidermolysis bullosa due to mutations in the keratin 14 gene, KRT14E Yiasemides, N Trisnowati, J Su, et al.
The British Journal of Dermatology|September 19, 2025
Methodological concerns in the EASE study of Oleogel-S10 for epidermolysis bullosa: reply from authorsDédée F Murrell, Christine Bodemer, Anna L Bruckner, et al.
The Journal of Investigative Dermatology|March 9, 2007
Retrospective diagnosis of fatal BP180-deficient non-Herlitz junctional epidermolysis bullosa suggested by immunofluorescence (IF) antigen-mapping of parental carriers bearing enamel defectsDedee F Murrell, Anna M G Pasmooij, Hendri H Pas, et al.
The Journal of Pathology|October 11, 2011
Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisitaZlatko Kopecki, Ruth M Arkell, Xanthe L Strudwick, et al.
The Australasian Journal of Dermatology|November 11, 2011
Autosomal dominant bullous dermolysis of the newborn associated with a heterozygous missense mutation p.G1673R in type VII collagenJohn Frew, Shueh W Lim, Alfred Klausseger, et al.
The British Journal of Dermatology|January 17, 2025
Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE studyDédée F Murrell, Christine Bodemer, Anna L Bruckner, et al.
The Journal of Allergy and Clinical Immunology|August 27, 2019
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritusJonathan I Silverberg, Andreas Pinter, Grazyna Pulka, et al.
Pageof 50

Showing results (391-400 of 491) with videos related to

Sort By:
Pageof 50
International Journal of Women'S Dermatology|May 12, 2017
The reliability and validity of outcome measures for atopic dermatitis in patients with pigmented skin: A grey areaC Y Zhao, A Wijayanti, M C Doria, et al.
Clinical and Experimental Dermatology|March 17, 2023
Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the Phase IIb CONTROL studyChristopher G Bunick, Joyce M C Teng, Scott Guenthner, et al.
The British Journal of Dermatology|May 14, 2013
A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopyP L Tong, J Qin, C L Cooper, et al.
Clinical and Experimental Dermatology|August 21, 2008
Clinical heterogeneity in recessive epidermolysis bullosa due to mutations in the keratin 14 gene, KRT14E Yiasemides, N Trisnowati, J Su, et al.
The British Journal of Dermatology|September 19, 2025
Methodological concerns in the EASE study of Oleogel-S10 for epidermolysis bullosa: reply from authorsDédée F Murrell, Christine Bodemer, Anna L Bruckner, et al.
The Journal of Investigative Dermatology|March 9, 2007
Retrospective diagnosis of fatal BP180-deficient non-Herlitz junctional epidermolysis bullosa suggested by immunofluorescence (IF) antigen-mapping of parental carriers bearing enamel defectsDedee F Murrell, Anna M G Pasmooij, Hendri H Pas, et al.
The Journal of Pathology|October 11, 2011
Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisitaZlatko Kopecki, Ruth M Arkell, Xanthe L Strudwick, et al.
The Australasian Journal of Dermatology|November 11, 2011
Autosomal dominant bullous dermolysis of the newborn associated with a heterozygous missense mutation p.G1673R in type VII collagenJohn Frew, Shueh W Lim, Alfred Klausseger, et al.
The British Journal of Dermatology|January 17, 2025
Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE studyDédée F Murrell, Christine Bodemer, Anna L Bruckner, et al.
The Journal of Allergy and Clinical Immunology|August 27, 2019
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritusJonathan I Silverberg, Andreas Pinter, Grazyna Pulka, et al.
Pageof 50